Kim Etchevers, MS

Gilead Sciences, Inc.
Foster City, California, United States

Disclosure(s): Gilead Sciences, Inc.: Employee, Stocks/Bonds (Public Company)

Presentation(s):

• 92 - Obeldesivir Reduced SARS-CoV-2 Infectious Titers in the BIRCH Phase 3 Clinical Trial

  Thursday, October 17, 2024
  11:30 AM – 11:43 AM US PT